Peter Altman Bio Cardia, Inc. (BCDA) insider trading activity

BCDA Quotes by TradingView

Peter Altman is President and CEO of BioCardia, Inc.. Currently has a direct ownership of 81,411 shares of BCDA, which is worth approximately $206,783. The most recent transaction as insider was on Sep 03, 2024, when has been sold 41,666 shares (Common Stock) at a price of $3.0 per share, resulting in proceeds of $124,998. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 81.4K
107.44% 3M change
81.8% 12M change
Total Value Held $206,783

Peter Altman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 03 2024
BUY
Grant, award, or other acquisition
$124,998 $3.0 p/Share
41,666 Added 33.85%
81,411 Common Stock
Jul 01 2024
BUY
Open market or private purchase
$915 $3.05 p/Share
300 Added 0.75%
39,745 Common Stock
Jun 28 2024
BUY
Open market or private purchase
$598 $2.99 p/Share
200 Added 0.5%
39,445 Common Stock
Jun 21 2024
BUY
Open market or private purchase
$1,645 $3.29 p/Share
500 Added 1.26%
39,245 Common Stock
Jun 14 2024
BUY
Open market or private purchase
$1,760 $3.52 p/Share
500 Added 1.27%
38,745 Common Stock
Jun 10 2024
BUY
Open market or private purchase
$3,360 $3.36 p/Share
1,000 Added 2.55%
38,245 Common Stock
Apr 19 2024
BUY
Open market or private purchase
$1,017 $0.37 p/Share
2,750 Added 0.49%
558,697 Common Stock
Mar 28 2024
BUY
Open market or private purchase
$195 $0.39 p/Share
500 Added 0.09%
555,947 Common Stock
Feb 13 2024
BUY
Open market or private purchase
$49,729 $0.46 p/Share
108,108 Added 16.29%
555,447 Common Stock
Aug 17 2023
BUY
Grant, award, or other acquisition
$3,480 $0.87 p/Share
4,000 Added 0.89%
447,339 Common Stock
Aug 14 2023
BUY
Grant, award, or other acquisition
$3,960 $0.88 p/Share
4,500 Added 1.0%
443,339 Common Stock
Jun 23 2023
BUY
Grant, award, or other acquisition
$15,025 $2.34 p/Share
6,421 Added 1.44%
438,839 Common Stock
May 31 2023
SELL
Payment of exercise price or tax liability
$65,173 $1.77 p/Share
36,821 Reduced 7.85%
432,418 Common Stock
May 26 2023
BUY
Open market or private purchase
$9,920 $1.6 p/Share
6,200 Added 1.3%
469,239 Common Stock
May 18 2023
BUY
Grant, award, or other acquisition
$185,850 $1.7 p/Share
109,324 Added 19.1%
463,039 Common Stock
Dec 16 2022
BUY
Grant, award, or other acquisition
$24,998 $1.68 p/Share
14,880 Added 4.1%
347,827 Common Stock
Sep 23 2022
BUY
Open market or private purchase
$2,618 $1.87 p/Share
1,400 Added 0.42%
328,447 Common Stock
Sep 22 2022
BUY
Open market or private purchase
$5,611 $1.81 p/Share
3,100 Added 0.94%
327,047 Common Stock
Sep 21 2022
BUY
Open market or private purchase
$5,280 $1.92 p/Share
2,750 Added 0.84%
323,947 Common Stock
Jun 10 2022
BUY
Open market or private purchase
$6,570 $1.46 p/Share
4,500 Added 1.38%
321,197 Common Stock
May 13 2022
BUY
Open market or private purchase
$3,723 $1.38 p/Share
2,698 Added 0.77%
348,143 Common Stock
May 12 2022
SELL
Payment of exercise price or tax liability
$41,509 $1.32 p/Share
31,446 Reduced 9.03%
316,697 Common Stock
May 12 2022
BUY
Open market or private purchase
$13,562 $1.2 p/Share
11,302 Added 3.17%
345,445 Common Stock
May 11 2022
BUY
Open market or private purchase
$1,300 $1.3 p/Share
1,000 Added 0.3%
334,143 Common Stock
Apr 29 2022
BUY
Open market or private purchase
$4,347 $1.61 p/Share
2,700 Added 0.8%
333,143 Common Stock
PA

Peter Altman

President and CEO
Sunnyvale, CA

Track Institutional and Insider Activities on BCDA

Follow BioCardia, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCDA shares.

Notify only if

Insider Trading

Get notified when an Bio Cardia, Inc. insider buys or sells BCDA shares.

Notify only if

News

Receive news related to BioCardia, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BCDA